The 80th Annual Meeting of the Japanese Society of Hematology

Presentation information

Print

Symposium

Symposium 8 Novel therapeutic strategy for AML

Sat. Oct 13, 2018 2:50 PM - 5:00 PM No.10 (Osaka International Convention Center, 10F 1009)

Chairs: Hitoshi Kiyoi (Department of Hematology and Oncoloogy , Nagoya University Graduate School of Medicine, Japan), Takahiro Yamauchi (Department of Hematology and Oncoloogy , Universityl of Fukui, Japan)

【Ｅ】

[SY8-2] Gilteritinib: a novel, small molecule FLT3/AXL inhibitor for the treatment of acute myeloid leukemia

Toshihiro Miyamoto (Medicine and Biosystemic Science, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan)

2001- Medicine and Biosystemic Science, Graduate School of Medical Sciences, Kyushu University
1998-2001 Department of Pathology & Developmental Biology, Stanford University, USA
1997-1998 Hamanomachi Hospital
1993-1997 Research Fellow, First Department of Internal Medicine, Kyushu University Hospital
1990-1993 Clinical Fellow, First Department of Internal Medicine, Kyushu University Hospital

Abstract password authentication.
Password is written on a program and abstract book.

Password